Creative Details

Quality Score: 6/10

The advertisement promotes Otezla (apremilast) as a treatment for plaque psoriasis, featuring a testimonial from a patient about their positive experience after four months of treatment. It also includes important safety information regarding potential side effects and allergic reactions.

Creative Information

CID:204cd81a-4ae3-4759-93c3-e4d6e4b0e63d
CRID:25_8kp1z6ap
Domain:otezlapro.com
Seat:TTD
Size:300x600
Bid:$3.77
Timestamp:11/7/2025, 5:11:28 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/18/2025, 8:30:47 PM7.90s
    adomain_analysissuccess11/18/2025, 9:05:43 PM2.49s
    adomain_capturesuccess11/18/2025, 9:05:41 PM0.23s
    ad_rendersuccess11/18/2025, 8:30:39 PM33.60s
    brand_mappingsuccess11/18/2025, 8:28:06 PM0.11s

    Analysis Results

    Ad Format: banner

    Brands: Otezla

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:300x600
    Data Transferred:1783.19 KB
    Render Time:8.58 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    Total Ad Size:1802.40 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js529.10
    https://code.createjs.com/1.0.0/createjs.min.js236.38
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js222.95
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N2525149.3848558MATTERKIND/B32932508.411815442;dc_ver=106.314;dc_eid=40004001;sz=300x600;u_sd=1;gdpr=0;nel=1;dc_adk=2027040026;ord=par34d;click=https%3A%2F%2Finsight.adsrvr.org%2Ftrack%2Fclk%3Fimp%3D50e7fc59-4558-44fe-9281-828753377fda%26ag%3Drachyop%26sfe%3D1b4ca31d%26sig%3D4KffUnyA82YwDPSASCXUBp5OJ65Fm_fB50xrXOiKHA8.%26crid%3D8kp1z6ap%26cf%3D9560104%26fq%3D0%26t%3D1%26td_s%3Dgames.usatoday.com%26rcats%3Denb%2Cy29%2C7sp%2Chhr%2Cv8t%26mste%3Dgames.usatoday.com%26mfld%3D2%26mssi%3D%26mfsi%3D%26sv%3Dkargo%26uhow%3D90%26agsa%3D%26wp%3D1.5171441%26rgz%3D77025%26dt%3DPC%26osf%3DWindows%26os%3DWindows10%26br%3DChrome%26svpid%3D201%26rlangs%3Den%26mlang%3D%26did%3D%26rcxt%3DOther%26tmpc%3D25.24000000000001%26vrtd%3D%26osi%3D%26osv%3D%26daid%3D%26dnr%3D0%26vpb%3D%26crrelr%3D%26npt%3D2%26cc%3D2~KLUv_WMdqREMTQQlGQDzY4K4XFtUbk1Uji0qx-XG5YYlStQQGgITHZYHxBgR5IcPPw5-nu6cKULlqnsrQqWHQKXvx6zQJZfK5b6dBI1hOSSGSY4uENiQ0F5DvHi7hDKURDWuz0NyJByS4-TaXGa6WdLrDCw_EqM-6nW39OIWi1JumTys0lB8uuObc5SpvXJRgdAfR3K50IC8m9jHPSmSaORyAc1w4a8n_IruyWM_xlXje1Cnky7hujYTkjWxyeDzzLq0QsHu_Aedv3RdSagPqhP7dUF_uY83pb9oM7vLZyYM_j7tE2nTyapzu4sFnz4-JjXeWyiuLLNhHla70z23Pd2VjupgZpL_oT4crejFu5NNozS4JTMDc5ph9TssKF0Ccb7ObtGkZ_KYzQUku_4-UUqEfV5E_Oel5G0kb62rYftTzCflYTGgUuaLQx0Q3kFvqrTINCJlYqz7EvbMaC5sCn8fT_fVk8mKYUduzR32pM2v5m7Hd0Chb5dlmtVLXydSCamSoKQlDYNNXxFMXf1_tnlbhue-1uH6reb93a91vo90hkkYQyzQRMzZoQmSjhpOejIO2xkImIpB1mfEFCwqlODauNltnEOxXRwb9lrHvXw9QQbS2pwuLNfy2f_zt-zr8N_v-zintXKd9qRJdZsbS9WwrXktoAIEj1Aa3Sp5nVrF4xPBDeYiBYocrw_Ur8wrkScz_6d_mJ61AlL8gFVwzkumY0E44oGn1UigftQ22TbLCeqGSOY1i7yY2WdFxtk8JjS11ucTpKiujT3B4BDflbslzvNpmKZ2ekbGfkDA33sP9vbNk3S1zVWZCwFi4YLoZxuEMtUvVMxmipsrR4a2h89scBshyPVt1VEWVbBCd0Kec15hpMjQkx5NUgnnuDqYZE23En7iaRSxOHXGGPuKWbjW7S25N0mGAFjTpS5OST4XzauE98L0I4WJtS_JBL_-ie79nKbOWCp7xrt3tkkFHagBLO8MWRF3lXHgCJN2cSuZhOY6rVzvk9Ubb8UToOVDKBQSIEMYhoTrGoFKMufcAELeeCknO58fOo0I7jNoK-lDP6EKHxP6DuI_Q3Z2Ys3ExCU.%26dur%3D1~KLUv_WMFoCgkawCdAgATxAwX2EALCnwiuMAKy6v9vblizq2GU18Ne9YUWok13JfjHelktZbwY4YsXuamJK9HMZ9pOQEJ_PRHYM9Ba7e-I2A6J8Q3SI1CNjTXE2H6A002nA..%26durs%3DWRIzNJ%26bdc%3D131%26uidd%3DdsKaei5YjwADHFA8bAkRkpCIz5zNTLW2CR-BDfHkH9ojdHR-%26idl%3DXi30071K2QMjLpr7nA0F-ILc2hFU0cpDUmbTs5tcQ6chPE8KPD0KpKefuWFJ6V2Zp_yw5c%26testid%3D%25236082C%2520TTDContextualTest%2520iavc1%2520%26fpa%3D133%26pcm%3D3%26ict%3DEthernet%26said%3D7de1ef49-dd3c-49a9-aca5-feb8ebec5cb3%26auct%3D1%26tail%3D1%26r%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=wPnY)q7HNf;gcsr=m;stc=1;chaa=1;sttr=74;prcl=s108.73
    https://cdnjs.cloudflare.com/ajax/libs/gsap/3.11.4/gsap.min.js69.49
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://s0.2mdn.net/sadbundle/5951386988356224487/A02_ANI_300X600_PATIENT-STORIES-PATRICK-DCM_AMGEN_OTEZLA/index.js52.50
    https://ep1.adtrafficquality.google/bg/DPVnEqOOr8GEkyz-5oBqyWDy70NS1PVNM5rSU7EcCeQ.js52.04
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2Creative Screenshot 3